引用次数
引用: 2,777
H-指数: 19
I10-指数 : 28
出版物: 104
579 POSTER Biological and biochemical activity of TLN-4601 in pancreatic cancer
P.M. Campbell , J.J. Fiordalisi , A.B. Hanker , N. Boufaied
Ejc Supplements 6 ( 12) 181 -182
2008
Abstract PD3-05: Co-occurring gain-of-function mutations in HER2 and HER3 cooperate to enhance HER2/HER3 binding, HER-dependent signaling, and breast cancer growth
AB Hanker , JP Koch , D Ye , G Sliwoski
Cancer Research 79
3
2019
Abstract P3-03-03: An acquired HER2 T798I gatekeeper mutation induces resistance to neratinib in a patient with HER2 mutant-driven breast cancer
AB Hanker , M Red Brewer , JH Sheehan , JP Koch
Cancer Research 77
2
2017
Co-occurring gain-of-function mutations in HER2 and HER3 cooperate to enhance HER2/HER3 binding, HER-dependent signaling, and breast cancer growth
AB Hanker , JP Koch , D Ye , G Sliwoski
CANCER RESEARCH 79 ( 4)
2019
Activating PIK3CA mutations induce an EGFR/ERK paracrine signaling axis in basal-like breast cancer
CD Young , LJ Zimmerman , D Hoshino , L Formisano
Mol Cell Proteomics 14 1959 -1976
7
2015
Mapping Cell-to-cell Interactions from Spatially Resolved Transcriptomics Data.
J Zhu , Y Wang , WY Chang , A Malewska
Biorxiv: the Preprint Server for Biology
2023
Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling.
A B Hanker , N Mitin , R S Wilder , E P Henske
Oncogene 29 ( 3) 380 -391
79
2010
Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies
A. B. Hanker , A. D. Pfefferle , J. M. Balko , M. G. Kuba
Proceedings of the National Academy of Sciences of the United States of America 110 ( 35) 14372 -14377
119
2013
FGFR1 associates with gene promoters and regulates gene transcription: Implications for endocrine resistance in ER+/FGFR1-amplified breast cancer
Alberto Servetto , Rahul Kollipara , Luigi Formisano , A Lin
2020
A platform of CDK4/6 inhibitor-resistant patient-derived breast cancer organoids illuminates mechanisms of resistance and therapeutic vulnerabilities
ABH Hanker , Sumanta Chatterjee , Yunguan Wang , Dan Ye
AACR; Cancer Res 82 ( 4 Suppl) Abstract nr PD2 -01
1
2022
Abstract GS1-06: FGFR1 associates with gene promoters and regulates gene transcription: Implications for endocrine resistance in ER+/FGFR1-amplified breast cancer
Dhivya R Sudhan , Ariella B Hanker , Luigi Formisano , Rahul Kollipara
Cancer Research 81
2021
A versatile oblique plane microscope for large-scale and high-resolution imaging of subcellular dynamics.
Etai Sapoznik , Bo-Jui Chang , Jaewon Huh , Robert J Ju
eLife 9 1 -39
81
2020
Romidepsin inhibits Ras-dependent growth transformation of NIH 3T3 fibroblasts and RIE-1 epithelial cells independently of Ras signaling inhibition
Ariella B Hanker , Kevin D Healy , Jean Nichols , Channing J Der
Journal of Molecular Signaling 4 ( 1) 5 -5
7
2009
Abstract PD7-04: Fibroblast growth factor receptor 1 associates with promoters genome-wide and regulates gene transcription in ER+/FGFR1-amplified breast cancer: Implications for endocrine resistance
Alberto Servetto , Rahul Kollipara , Luigi Formisano , Kyung-min Lee
Cancer Research 80
2020
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2 -positive breast cancer
Michalina Janiszewska , Lin Liu , Vanessa Almendro , Yanan Kuang
Nature Genetics 47 ( 10) 1212 -1219
107
2015
Epigenetic repression of STING by MYC promotes immune evasion and resistance to immune checkpoint inhibitors in triple-negative breast cancer
Kyung-min Lee , Chang-Ching Lin , Alberto Servetto , Joonbeom Bae
Cancer Immunology Research 10 ( 7) 829 -843
2
2022
Abstract P5-17-09: A genome-wide CRISPR screen identifies PRMT5 as a novel therapeutic target in ER+/RB1-deficient breast cancer
Chang-Ching Lin , Tsung-Cheng Chang , Alberto Servetto , Kyung-min Lee
Cancer Research 82 ( 4\_Supplement) P5 -17
2022
Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity
Ariella B Hanker , Benjamin P Brown , Jens Meiler , Arnaldo Marín
Cancer Cell 39 ( 8) 1099 -1114
28
2021
gain-of-function kinase library screen identifies FGFR1 amplification as a mechanism of resistance to antiestrogens and CDK4/6 inhibitors in ER+ breast cancer
Luigi Formisano , Yao Lu , Valerie M Jansen , Joshua A Bauer
Cancer Research 77 ( 13\_Supplement) 1008 -1008
13
2017
Acquired secondary HER2 mutations enhance HER2/MAPK signaling and promote resistance to HER2 kinase inhibition in breast cancer
Arnaldo Marín , Abdullah Al Mamun , Hima Patel , Hiroaki Akamatsu
Cancer research 83 ( 18) 3145 -3158
4
2023
Dhivya R. Sudhan Kyung-min Lee Alberto Servetto Alshad S. Lalani Jens Meiler Sumanta Chatterjee, PhD Rebecca S. Cook Angel Guerrero-Zotano Saurabh Mendiratta Jonathan H. Sheehan Justin M. Balko Gregory Sliwoski Reto Fiolka Ralf Kittler David M Hyman Zhongming Zhao Feixiong Cheng Luigi Formisano David Solit Adam D. Pfefferle